NSI Logo

Evolving Innovative Solutions™ - Since 1993

People

Chief Executive Officer

Gary B. Fogel, Ph.D.

President

David B. Fogel, Ph.D.

Senior Staff Scientists

George H. Burgin, Ph.D.

Joe Rothermich

Karl M. Torgerson

Sevan Ficici, Ph.D.

Tim Hays

Staff Scientist

Enoch Liu

Facility Security Officer

Vincent William (Bill) Porto

Chief Executive Officer

Dr. Gary B. Fogel joined Natural Selection, Inc. in 1998 after completing the Ph.D. in biology from UCLA. His current research interests focus on the application of computational intelligence methods to problems in the biomedical sciences. These include biomarker discovery, sequence analysis, microRNA discovery, drug design, improved diagnosis, and biomedical pattern recognition. Dr. Fogel leads Natural Selection, Inc.'s efforts in biomedicine but also has led projects for industrial and defense related applications.

Dr. Fogel is a Fellow of the IEEE and member of Sigma Xi. He currently serves as editor-in-chief of BioSystems and as an associate editor for IEEE Transactions on Evolutionary Computation. He co-edited a volume on Evolutionary Computation in Bioinformatics published in 2003 (Morgan Kaufmann) and Computational Intelligence in Bioinformatics, published in 2008 (Wiley-IEEE Press). Dr. Fogel has assisted with many conferences and served as Conference Chair for the 2010 IEEE Congress on Evolutionary Computation, and as general chair for the 2004 and 2005 IEEE Symposia on Computational Intelligence in Bioinformatics and Computational Biology. Dr. Fogel serves on the IEEE Computational Intelligence Society Executive Committee (ExCom) as Vice President for Conferences (2010-2012).

Dr. Fogel's responsibilities as CEO are to provide leadership towards maintaining Natural Selection, Inc.'s excellence in real-world applications of computational intelligence methods. Dr. Fogel assists in developing and advancing a company strategic plan for its mission and objectives and promotes revenue, profitability, and growth. Dr. Fogel oversees business operations to ensure production efficiency, quality, service, and cost-effective management of resources. He assists in developing and authorizing company operational procedures, policies, and standards.

Selected Publications

Hecht D, Fogel GB (2012) "Towards Predictive Structure-based Models of Evolved Drug Resistance," 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, San Diego, CA. accepted.

Ficici S, Liu E, Fogel GB (2012) "Evolutionary Algorithms for Supertree Search," 2012 IEEE World Congress on Computational Intelligence, Brisbane, Australia, accepted.

Dillman RO, Fogel GB, Comforth AN, Selvan SR, Schiltz PM, Deprist C (2011) "Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines," Cancer Biother Radiopharm, Vol. 26(4), pp. 407-15.

Hecht D, Tran J, Fogel GB (2011) "Structural-based analysis of dihydrofolate reductase evolution," Molecular Phylogenetics and Evolution, Vol. 61(1), pp. 212-30.

Lamers SL, Fogel GB, McGrath MS (2010) "HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis?" Current HIV Research, Vol. 8(8), pp.638-640.

For more information please see the NSI Publications Library or email Dr. Gary Fogel at: gfogel [at] natural-selection.com